Navigation Links
Will Brazil, Russia, India and China Ever Become the Golden Goose of the Future for Life Science and Medical Device Companies?
Date:4/3/2013

SAO PAULO, April 3, 2013 /PRNewswire/ --WHEN:11:00 a.m. EDT on Tuesday, May 7, 2013 LOCATION:Online, with free registrationMODERATOR:Frost & Sullivan Partner Reenita DasSPEAKERS:Latin America Healthcare Leader Eduardo GolisanoSouth Asia and Middle East Healthcare Director Sandeep SinhaChina Healthcare Director Xuchao Glenn HouAdvanced Medical Technologies Global Program Manager Siddharth SahaMultinational firms have been exploring opportunities in emerging markets as a strategy to face the Western slowdown. However, after facing limited growth in these regions during 2012, the major drug and device manufacturers are obliged to reassess their strategies.  Heavyweights of the drug business, including Pfizer Inc., Merck, Bristol-Myers Squibb, GlaxoSmithKline and Novartis, are discovering that conquering markets in countries such as Brazil, Russia, India and China (BRIC) is not as easy as originally assumed.

Attend this webinar to discover:

  • Insight from BRIC healthcare leaders as they share field experiences and best practices gathered through hundreds of successful cases
  • Common obstacles international companies must overcome in these regions
  • How to exploit the hidden potential of BRIC countries
  • Tactics to adjust strategy to successfully penetrate BRIC markets
  • The top 10 technologies and products expected to drive growth in these regions
  • The briefing will benefit any senior manager in the corporate strategy or global marketing areas that focuses on emerging markets, as well as any healthcare company looking to explore BRIC countries.

    Supporting Quote"Our team of more than 40 healthcare analysts on the ground in these four countries amassed an array of best practices of what works and what does not, based on actual experiences working through the regionally-specific barriers and opportunities alike," said Frost & Sullivan Partner Reenita Das , who will moderate this webinar.  "These best practices provide excellent lessons learned in the trenches through hands-on experience, which will be very beneficial for any company currently in these markets or looking to enter in the future.  Our analysts have blazed the path to come out on the other side each time, more knowledgeable of the most opportune passageway."

    Supporting ResourcesFor more information about Frost & Sullivan's Healthcare practice, please visit: http://www.healthcare.frost.com.

    Registration

  • To attend the briefing, email francesca.valente@frost.com your full name, job title, company name, company telephone number, company email address and website, city, state and country.
  • Receive a recorded version of the briefing anytime by submitting the aforementioned contact details.
  • About Frost & SullivanFrost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

    Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
  • For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

    Contact Us:
    Start the discussion

    Join Us:
    Join our community

    Subscribe:
    Newsletter on "the next big thing"

    Register:
    Gain access to visionary innovation

    Contact:
    Francesca Valente
    Frost & Sullivan
    + 54 11 4777 5300
    francesca.valente@frost.com


    '/>"/>
    SOURCE Frost & Sullivan
    Copyright©2012 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Diagnostic Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
    2. Incontinence Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
    3. Arthroscopy Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
    4. Orthopedic Braces and Supports Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
    5. Peripheral Vascular Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
    6. Trovagene and Barretos Cancer Hospital, Brazil, to Evaluate Urine-Based HPV Assay as Potential Pap Smear Replacement
    7. Respiratory Disposables Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
    8. Dental Lasers Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
    9. Dental Radiology Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
    10. Pressure Relief Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
    11. X-Ray Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/28/2017)... -- Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), ... Christopher Gabrieli , partner ... chairman of the board of Akcea Therapeutics. ... Laboratories. Sandford D. Smith , founder ... "We are excited to announce this expansion to our board ...
    (Date:3/28/2017)... ROCKVILLE, Md. , March 28, 2017 /PRNewswire/ ... dedicated to innovative therapeutics addressing cancer and other ... at the American Association for Cancer Research annual ... April 3 is entitled "Evaluation of ENMD-2076 ... and the second poster to be presented ...
    (Date:3/28/2017)... 28, 2017 The global ... a value of USD 4.5 billion by 2025, according ... Proper closure of injured tissues post operation is a ... leakages occur in 3% to 15% of cases and ... for one third of postoperative deaths in patients. Surgical ...
    Breaking Medicine Technology:
    (Date:3/28/2017)... ... ... Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts of the world, is ... about journey and research recently on a blog and discussed some major aspects of ... deal with thyroid disease. , Dr. Wentz completed her graduation from the Midwestern ...
    (Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a leader ... Emergency Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products are the ... their kind, the iSAFE and iSAFE Plus offer direct GPS Location and two-way calling ...
    (Date:3/28/2017)... ... 28, 2017 , ... Calibration, qualification, and the appropriate level ... maintaining GMP and USP compliance. In a new webinar from METTLER TOLEDO entitled ... these requirements are explained. The challenge is to determine how to put ...
    (Date:3/28/2017)... ... March 28, 2017 , ... METTLER ... ions found in power plant water and steam. , Chlorides and sulfates cause ... boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at low ...
    (Date:3/28/2017)... ... March 28, 2017 , ... AutismOne announced the Board Certified ... Integrative Medicine and available for application on Saturday, May 27, 2017, following Thursday, ... Colorado Springs. , Ed Arranga, president of AutismOne, stated: "Many of the modalities ...
    Breaking Medicine News(10 mins):